.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A04A_AntiemeticsAndAntinauseants.A04AD01_Scopolamine.Scopolamine_1 .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A04A_AntiemeticsAndAntinauseants.A04AD01_Scopolamine.Scopolamine_1| name: | Scopolamine_1 | |
| ATC code: | A04AD01_1 | |
| route: | transdermal | |
| compartments: | 2 | |
| dosage: | 1.5 | mg |
| volume of distribution: | 5.0 | L |
| clearance: | 1.4 | L/h/kg |
| other parameters in model implementation | ||
Scopolamine (also known as hyoscine) is a tropane alkaloid with antimuscarinic properties, primarily used to prevent nausea and vomiting associated with motion sickness and postoperative recovery. It is FDA-approved and commonly administered as a transdermal patch or parenterally.
Pharmacokinetic parameters following transdermal administration (scopolamine patch) in healthy adult volunteers.
Delgado-Charro, MB, & Guy, RH (2014). Effective use of transdermal drug delivery in children. Advanced drug delivery reviews 73 63–82. DOI:10.1016/j.addr.2013.11.014 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24333231
Berner, B, & John, VA (1994). Pharmacokinetic characterisation of transdermal delivery systems. Clinical pharmacokinetics 26(2) 121–134. DOI:10.2165/00003088-199426020-00005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/8162656
Guay, DR (2003). Clinical pharmacokinetics of drugs used to treat urge incontinence. Clinical pharmacokinetics 42(14) 1243–1285. DOI:10.2165/00003088-200342140-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14606931